BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jonsson R, Moen K, Vestrheim D, Szodoray P. Current issues in Sjögren's syndrome: Sjögren's syndrome. Oral Diseases 2002;8:130-40. [DOI: 10.1034/j.1601-0825.2002.02846.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Bayetto K, Logan RM. Sjögren's syndrome: a review of aetiology, pathogenesis, diagnosis and management. Aust Dent J 2010;55 Suppl 1:39-47. [PMID: 20553243 DOI: 10.1111/j.1834-7819.2010.01197.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
2 Porter S, Scully C, Hegarty A. An update of the etiology and management of xerostomia. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2004;97:28-46. [DOI: 10.1016/j.tripleo.2003.07.010] [Cited by in Crossref: 210] [Cited by in F6Publishing: 156] [Article Influence: 11.7] [Reference Citation Analysis]
3 Gibson J, Halliday JA, Ewert K, Robertson S. A controlled release pilocarpine buccal insert in the treatment of Sjögren's syndrome. Br Dent J 2007;202:E17; discussion 404-5. [PMID: 17273177 DOI: 10.1038/bdj.2007.80] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
4 Osnes LT, Nakken B, Bodolay E, Szodoray P. Assessment of intracellular cytokines and regulatory cells in patients with autoimmune diseases and primary immunodeficiencies - novel tool for diagnostics and patient follow-up. Autoimmun Rev 2013;12:967-71. [PMID: 23541481 DOI: 10.1016/j.autrev.2013.02.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
5 Bingle CD, Gorr SU. Host defense in oral and airway epithelia: chromosome 20 contributes a new protein family. Int J Biochem Cell Biol 2004;36:2144-52. [PMID: 15313462 DOI: 10.1016/j.biocel.2004.05.002] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
6 Vinke J, Kaper HJ, Vissink A, Sharma PK. An ex vivo salivary lubrication system to mimic xerostomic conditions and to predict the lubricating properties of xerostomia relieving agents. Sci Rep 2018;8:9087. [PMID: 29904095 DOI: 10.1038/s41598-018-27380-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
7 Keinan D, Leigh NJ, Nelson JW, De Oleo L, Baker OJ. Understanding resolvin signaling pathways to improve oral health. Int J Mol Sci 2013;14:5501-18. [PMID: 23528855 DOI: 10.3390/ijms14035501] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
8 Gambino A, Broccoletti R, Cafaro A, Cabras M, Carcieri P, Arduino PG. Impact of a sodium carbonate spray combined with professional oral hygiene procedures in patients with Sjögren's syndrome: an explorative study. Gerodontology 2017;34:208-14. [PMID: 27813150 DOI: 10.1111/ger.12250] [Reference Citation Analysis]
9 Szodoray P, Jonsson R, Brun JG, Zeher M. Polymyalgia rheumatica in primary Sjögren's syndrome. Rheumatol Int 2006;26:401-3. [PMID: 15988601 DOI: 10.1007/s00296-005-0010-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Szodoray P, Jellestad S, Ohlsson Teague M, Jonsson R. Attenuated Apoptosis of B Cell Activating Factor–Expressing Cells in Primary Sjögren’s Syndrome. Lab Invest 2003;83:357-65. [DOI: 10.1097/01.lab.0000059930.92336.e2] [Cited by in Crossref: 48] [Article Influence: 2.5] [Reference Citation Analysis]
11 Dos Santos HT, Nam K, Maslow F, Trump B, Baker OJ. Specialized pro-resolving receptors are expressed in salivary glands with Sjögren's syndrome. Ann Diagn Pathol 2021;56:151865. [PMID: 34847389 DOI: 10.1016/j.anndiagpath.2021.151865] [Reference Citation Analysis]
12 Zilahi E, Chen J, Papp G, Szántó A, Zeher M. Lack of association of vitamin D receptor gene polymorphisms/haplotypes in Sjögren’s syndrome. Clin Rheumatol 2015;34:247-53. [DOI: 10.1007/s10067-014-2639-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
13 Nair JJ, Singh TP. Sjogren's syndrome: Review of the aetiology, Pathophysiology & Potential therapeutic interventions. J Clin Exp Dent 2017;9:e584-9. [PMID: 28469828 DOI: 10.4317/jced.53605] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
14 Horvath IF, Szodoray P, Zeher M. Primary Sjögren's syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients. Clin Rheumatol 2008;27:1479-83. [PMID: 18553114 DOI: 10.1007/s10067-008-0944-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
15 Fox RI. Sjogren’s syndrome: evolving therapies. Expert Opinion on Investigational Drugs 2005;12:247-54. [DOI: 10.1517/13543784.12.2.247] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
16 Aliko A, Ciancaglini R, Alushi A, Tafaj A. Sicca symptoms, and lacrimal and salivary flow in Albanian patients with rheumatoid arthritis: Sicca symptoms and signs in RA. Journal of Oral Pathology & Medicine 2010;39:651-6. [DOI: 10.1111/j.1600-0714.2010.00899.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
17 Zeher M, Horvath IF, Szanto A, Szodoray P. Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögren's syndrome. Thyroid 2009;19:39-45. [PMID: 19119981 DOI: 10.1089/thy.2007.0398] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
18 Lio CT, Dhanda SK, Bose T. Cluster Analysis of Dry Eye Disease Models Based on Immune Cell Parameters - New Insight Into Therapeutic Perspective. Front Immunol 2020;11:1930. [PMID: 33133058 DOI: 10.3389/fimmu.2020.01930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Pillemer SR. Lymphoma and other malignancies in primary Sjögren's syndrome. Ann Rheum Dis 2006;65:704-6. [PMID: 16699050 DOI: 10.1136/ard.2005.044362] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
20 de Souza TR, de Albuquerque Tavares Carvalho A, Duarte ÂP, Porter SR, Leão JC, Gueiros LA. Th1 and Th2 polymorphisms in Sjögren's syndrome and rheumatoid arthritis. J Oral Pathol Med 2014;43:418-26. [DOI: 10.1111/jop.12149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
21 Leigh NJ, Nelson JW, Mellas RE, Aguirre A, Baker OJ. Expression of resolvin D1 biosynthetic pathways in salivary epithelium. J Dent Res 2014;93:300-5. [PMID: 24389810 DOI: 10.1177/0022034513519108] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
22 Ibrahim OM, Dogru M, Kawashima S, Wakamatsu TH, Tsubota K, Fujishima H. Visante optical coherence tomography and tear function test evaluation of cholinergic treatment response in patients with sjögren syndrome. Cornea 2013;32:653-7. [PMID: 23146930 DOI: 10.1097/ICO.0b013e318261eb4a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
23 Psianou K, Panagoulias I, Papanastasiou AD, de Lastic A, Rodi M, Spantidea PI, Degn SE, Georgiou P, Mouzaki A. Clinical and immunological parameters of Sjögren's syndrome. Autoimmunity Reviews 2018;17:1053-64. [DOI: 10.1016/j.autrev.2018.05.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
24 Borrego-Sanz L, Sáenz-Francés San Baldomero F, Díaz Valle D, Santos Bueso E, Sánchez Jean R, Martínez de la Casa JM, Benítez Del Castillo JM, García Feijóo J, Rodríguez Rodríguez L. Comparison of corneal biomechanical properties of patients with dry eye secondary to Sjögren's syndrome and healthy subjects. J Fr Ophtalmol 2018;41:802-8. [PMID: 30342779 DOI: 10.1016/j.jfo.2018.02.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Schegg V, Vogel M, Didichenko S, Stadler MB, Beleznay Z, Gadola S, Sengupta C, Stadler BM, Miescher SM. Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R. Biologicals 2008;36:213-22. [PMID: 18249005 DOI: 10.1016/j.biologicals.2007.11.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
26 García-Carrasco M, Fuentes-Alexandro S, Escárcega RO, Salgado G, Riebeling C, Cervera R. Pathophysiology of Sjögren's syndrome. Arch Med Res 2006;37:921-32. [PMID: 17045106 DOI: 10.1016/j.arcmed.2006.08.002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
27 Gannot G, Tangrea MA, Gillespie JW, Erickson HS, Wallis BS, Leakan RA, Knezevic V, Hartmann DP, Chuaqui RF, Emmert-Buck MR. Layered peptide arrays: high-throughput antibody screening of clinical samples. J Mol Diagn 2005;7:427-36. [PMID: 16237212 DOI: 10.1016/S1525-1578(10)60573-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Maruyama T, Saito I, Hayashi Y, Kompfner E, Fox RI, Burton DR, Ditzel HJ. Molecular analysis of the human autoantibody response to alpha-fodrin in Sjögren's syndrome reveals novel apoptosis-induced specificity. Am J Pathol 2004;165:53-61. [PMID: 15215161 DOI: 10.1016/s0002-9440(10)63274-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
29 Li H, Dai M, Zhuang Y. A T cell intrinsic role of Id3 in a mouse model for primary Sjogren's syndrome. Immunity 2004;21:551-60. [PMID: 15485632 DOI: 10.1016/j.immuni.2004.08.013] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 5.1] [Reference Citation Analysis]
30 Szodoray P, Horvath IF, Papp G, Barath S, Gyimesi E, Csathy L, Kappelmayer J, Sipka S, Duttaroy AK, Nakken B, Zeher M. The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2010;49:211-7. [PMID: 19946023 DOI: 10.1093/rheumatology/kep374] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
31 Shivhare P, Gupta A, Yadav M, Konidena A, Shankarnarayan L. Evaluation of different diagnostic criteria of diseases manifesting the oral cavity - A review. Part-1. J Oral Biol Craniofac Res 2016;6:135-41. [PMID: 27195212 DOI: 10.1016/j.jobcr.2015.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Baker OJ, Camden JM, Rome DE, Seye CI, Weisman GA. P2Y2 nucleotide receptor activation up-regulates vascular cell adhesion molecule-1 [corrected] expression and enhances lymphocyte adherence to a human submandibular gland cell line. Mol Immunol 2008;45:65-75. [PMID: 17599409 DOI: 10.1016/j.molimm.2007.05.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
33 Siddiqui H, Chen T, Aliko A, Mydel PM, Jonsson R, Olsen I. Microbiological and bioinformatics analysis of primary Sjogren's syndrome patients with normal salivation. J Oral Microbiol 2016;8:31119. [PMID: 27770517 DOI: 10.3402/jom.v8.31119] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
34 Nagy G, Huszthy PC, Fossum E, Konttinen Y, Nakken B, Szodoray P. Selected Aspects in the Pathogenesis of Autoimmune Diseases. Mediators Inflamm 2015;2015:351732. [PMID: 26300591 DOI: 10.1155/2015/351732] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
35 Szodoray P, Jellestad S, Alex P, Zhou T, Wilson PC, Centola M, Brun JG, Jonsson R. Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjögren's syndrome with a special emphasis on BAFF. J Clin Immunol 2004;24:600-11. [PMID: 15622444 DOI: 10.1007/s10875-004-6240-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
36 Horvath S, Nazmul-Hossain AN, Pollard RP, Kroese FG, Vissink A, Kallenberg CG, Spijkervet FK, Bootsma H, Michie SA, Gorr SU, Peck AB, Cai C, Zhou H, Wong DT. Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model. Arthritis Res Ther 2012;14:R238. [PMID: 23116360 DOI: 10.1186/ar4081] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
37 Chinthamani S, Odusanwo O, Mondal N, Nelson J, Neelamegham S, Baker OJ. Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium. Am J Physiol Cell Physiol 2012;302:C968-78. [PMID: 22205391 DOI: 10.1152/ajpcell.00259.2011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
38 Wang D, Xue L, Yang Y, Hu J, Li G, Piao X. Temporal gene expression analysis of Sjögren’s syndrome in C57BL/6.NOD-Aec1Aec2 mice based on microarray time-series data using an improved empirical Bayes approach. Mol Biol Rep 2014;41:5953-60. [DOI: 10.1007/s11033-014-3471-4] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Aliko A, Alushi A, Tafaj A, Isufi R. Evaluation of the clinical efficacy of Biotène Oral Balance in patients with secondary Sjögren’s syndrome: a pilot study. Rheumatol Int 2012;32:2877-81. [DOI: 10.1007/s00296-011-2085-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
40 Lester S, Danda D, Cavill D, Pile K, Downie-Doyle S, Rischmueller M. Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjögren's syndrome. Arthritis Rheum 2003;48:3293-4. [PMID: 14613296 DOI: 10.1002/art.11309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Gøransson L, Haldorsen K, Brun J, Harboe E, Jonsson M, Skarstein K, Time K, Omdal R. The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties. Scandinavian Journal of Rheumatology 2010;40:221-4. [DOI: 10.3109/03009742.2010.536164] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 6.0] [Reference Citation Analysis]
42 Saito K, Mori S, Date F, Ono M. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand. Autoimmunity 2013;46:231-7. [PMID: 23301790 DOI: 10.3109/08916934.2012.757307] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
43 Sáfrány E, Pazár B, Csöngei V, Járomi L, Polgár N, Sipeky C, Horváth IF, Zeher M, Poór G, Melegh B. Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjögren syndrome in Hungarian population samples. Scand J Immunol. 2009;70:68-74. [PMID: 19522770 DOI: 10.1111/j.1365-3083.2009.02265.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
44 Hayakawa I, Tedder TF, Zhuang Y. B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice. Immunology 2007;122:73-9. [PMID: 17472721 DOI: 10.1111/j.1365-2567.2007.02614.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
45 Nakken B, Bodolay E, Szodoray P. Cytokine Milieu in Undifferentiated Connective Tissue Disease: a Comprehensive Review. Clin Rev Allergy Immunol 2015;49:152-62. [PMID: 25274451 DOI: 10.1007/s12016-014-8452-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
46 Moen K, Bertelsen L, Hellem S, Jonsson R, Brun J. Salivary gland and temporomandibular joint involvement in rheumatoid arthritis: relation to disease activity. Oral Diseases 2005;11:27-34. [DOI: 10.1111/j.1601-0825.2004.01054.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
47 Gao Y, Chen Y, Zhang Z, Yu X, Zheng J. Recent Advances in Mouse Models of Sjögren's Syndrome. Front Immunol 2020;11:1158. [PMID: 32695097 DOI: 10.3389/fimmu.2020.01158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Guinn AC, Rouleau TS, Brennan MT. Burning tongue and lips. Diagnosis: Sjögren syndrome with concurrent candidal infection. J Am Dent Assoc 2010;141:541-5. [PMID: 20436101 DOI: 10.14219/jada.archive.2010.0226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
49 Bose T, Diedrichs-möhring M, Wildner G. Dry eye disease and uveitis: A closer look at immune mechanisms in animal models of two ocular autoimmune diseases. Autoimmunity Reviews 2016;15:1181-92. [DOI: 10.1016/j.autrev.2016.09.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
50 Szodoray P, Papp G, Horvath IF, Barath S, Sipka S, Nakken B, Zeher M. Cells with regulatory function of the innate and adaptive immune system in primary Sjögren's syndrome. Clin Exp Immunol 2009;157:343-9. [PMID: 19664141 DOI: 10.1111/j.1365-2249.2009.03966.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
51 Likar-Manookin K, Stewart C, Al-Hashimi I, Curtis W, Berg K, Cherian K, Lockhart PB, Brennan MT. Prevalence of oral lesions of autoimmune etiology in patients with primary Sjogren's syndrome. Oral Dis 2013;19:598-603. [PMID: 23279206 DOI: 10.1111/odi.12044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
52 Iwamoto N, Kawakami A, Arima K, Nakamura H, Kawashiri S, Tamai M, Kita J, Okada A, Koga T, Kamachi M, Yamasaki S, Ichinose K, Ida H, Origuchi T, Eguchi K. Regulation of disease susceptibility and mononuclear cell infiltration into the labial salivary glands of Sjogren's syndrome by monocyte chemotactic protein-1. Rheumatology 2010;49:1472-8. [DOI: 10.1093/rheumatology/keq079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
53 Uchida K, Akita Y, Matsuo K, Fujiwara S, Nakagawa A, Kazaoka Y, Hachiya H, Naganawa Y, Oh-Iwa I, Ohura K, Saga S, Kawai T, Matsumoto Y, Shimozato K, Kozaki K. Identification of specific autoantigens in Sjögren's syndrome by SEREX. Immunology 2005;116:53-63. [PMID: 16108817 DOI: 10.1111/j.1365-2567.2005.02197.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
54 Matsumoto Y, Ibrahim OMA, Kojima T, Dogru M, Shimazaki J, Tsubota K. Corneal In Vivo Laser-Scanning Confocal Microscopy Findings in Dry Eye Patients with Sjögren's Syndrome. Diagnostics (Basel) 2020;10:E497. [PMID: 32698387 DOI: 10.3390/diagnostics10070497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 Szodoray P, Alex P, Brun JG, Centola M, Jonsson R. Circulating cytokines in primary Sjögren's syndrome determined by a multiplex cytokine array system. Scand J Immunol 2004;59:592-9. [PMID: 15182255 DOI: 10.1111/j.0300-9475.2004.01432.x] [Cited by in Crossref: 128] [Cited by in F6Publishing: 122] [Article Influence: 7.1] [Reference Citation Analysis]